Shane Olwill

Shane Olwill

Former Senior Vice President and Chief Development OfficeratPalvella Therapeutics· In the 2023 proxy

Pay in FY2023Palvella Therapeutics stock -82.5% the same year

Shane Olwill was paid $705.4K in FY2023 (Dec). Palvella Therapeutics stock fell 82.5% that year.

Pay$100 in the stock at the end of FY22 → $18
Pay is from the Summary Compensation Table of each Palvella Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Palvella TherapeuticsPublic company · 3 yr
    • Former Senior Vice President and Chief Development Officer2023 – Present · 3 yrStock in role +109%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?